$7.19
0.00%
Nasdaq, Fri, Sep 25 2026.

Iteris, Inc. Stock price

$7.19
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+2.95 69.58% 3Y
+1.65 29.78% 5Y
+3.45 92.25% 10Y
+4.75 194.67% 20Y
Nasdaq, Closing price Fri, Sep 25 2026
+0.00 0.00%

Is Iteris, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
239.7
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
56.6%
Return on Equity
4.5%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
- | $191.0m
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
- | 11.0%
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
-
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
-
FCF per Share
-
Short interest
1.8%
Employees
463
Rev per Employee
$370.0k

Iteris, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Iteris, Inc. forecast:

4x Hold
44%
5x Sell
56%

Analyst Opinions

9 Analysts have issued a Iteris, Inc. forecast:

Hold
44%
Sell
56%

Financial data from Iteris, Inc.

Jun '24
+/-
%
174 174
5% 5%
100%
- Direct Costs 109 109
7% 7%
63%
65 65
34% 34%
37%
- Selling and Administrative Expenses 51 51
12% 12%
29%
- Research and Development Expense 11 11
29% 29%
6%
3.72 3.72
174% 174%
2%
- Depreciation and Amortization 2.60 2.60
0% 0%
1%
EBIT (Operating Income) EBIT 1.12 1.12
115% 115%
1%
Net Profit 1.40 1.40
118% 118%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Iteris, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Iteris, Inc. Stock News

Neutral
Business Wire
●
3 months ago
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company focused on developing transformative immune therapies through its proprietary UNITE® platform, announced today that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has cleared the Clinical Trial Notification (CTN) for ITI-9001, the Company's investigational immunotherapy fo...
Neutral
GlobeNewsWire
●
4 months ago
Key certification milestone underscores capability for seamless and secure communication with connected vehicles and infrastructure components Key certification milestone underscores capability for seamless and secure communication with connected vehicles and infrastructure components
Neutral
GlobeNewsWire
●
4 months ago
AUSTIN, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- Iteris, Inc., the world's trusted technology ecosystem for smart mobility infrastructure management and part of the Almaviva Group, today announced the launch of Iteris VantageNode™, a compact, AI-powered intersection detection solution designed to deliver high-performance vehicle, pedestrian, and bicycle detection at small, underserved, and less ...
More Iteris, Inc. News

Company Profile

Iteris, Inc. engages in the provision of information solutions for both the traffic management and global agribusiness markets. It operates through the following segments: Roadway Sensors; Transportation Systems; and Agriculture and Weather Analytics. The Roadway Sensors segment offers various vehicle detection and information systems and products for traffic intersection control, incident detection, and roadway traffic data collection applications. The Transportation Systems segment includes transportation engineering and consulting services. The Agriculture and Weather Analytics segment consists of ClearAg solutions and ClearPath Weather management tools, which deliver road maintenance applications and digital agriculture platforms, respectively. The company was founded by Joel Slutzky in 1969 and is headquartered in Santa Ana, CA.

Head office United States
CEO Mr. Bergera
Employees 463
Founded 1969
Website www.iteris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today